Parliamentary questions

886. Deputy Ken O'Flynn asked the Minister for Health if the change in coding classification from ICD-10-AM 10th edition to 12th edition in 2024 has been assessed for its impact on the comparability of obesity-related discharge data; and if a methodology note will be published to allow accurate year-on-year analysis. [47806/26]

887. Deputy Ken O'Flynn asked the Minister for Health the total number of compliance inspections, audits and reviews conducted nationally under the home support authorisation scheme, broken down by year since the scheme’s commencement in 2023 and by integrated health area; the number of approved providers issued with a quality improvement plan in each of those years; the number of providers whose …

888. Deputy Ken O'Flynn asked the Minister for Health whether the publicly available productivity dashboard for hospitals disaggregates data by the six health regions or only by individual hospital; and if it does not provide a regional breakdown, if she will commit to developing a dedicated comparative dashboard for the six health regions covering expenditure, workforce allocation, waiting times …

889. Deputy Ken O'Flynn asked the Minister for Health the specific tools, reports or mechanisms that currently allow for a direct comparison of performance between the six health regions, given that the health system performance assessment framework operates at aggregate national level only; and if she will provide a list of all such tools currently in use. [47809/26]

890. Deputy Ken O'Flynn asked the Minister for Health the mechanism which exists to compare the performance of the six regional executive officers against one another, given that responsibility for regional performance rests with the REOs individually; and if no such comparative mechanism exists, the way in which regional underperformance is identified relative to other regions rather than solely …

891. Deputy Ken O'Flynn asked the Minister for Health the timeline for making trauma-informed practice training mandatory for staff working with care-experienced young adults transitioning from CAMHS to adult mental health services; which staff cohorts will be prioritised; and if she will make a statement on the matter. [47811/26]

892. Deputy Ken O'Flynn asked the Minister for Health whether the absence of a national reporting structure for trauma-informed practice training uptake has been recorded on any HSE risk register or audit plan; and if she will make a statement on the matter. [47812/26]

893. Deputy Ken O'Flynn asked the Minister for Health the number and percentage, by community healthcare organisation, of staff currently engaging in CAMHS-to-adult mental health transition cases who have received no trauma-informed practice training; and if she will make a statement on the matter. [47813/26]

894. Deputy Ken O'Flynn asked the Minister for Health if she will direct the HSE to establish a distinct, trackable budget line for obesity-related healthcare expenditure; the timeline for same; and if she will make a statement on the matter. [47827/26]

895. Deputy Ken O'Flynn asked the Minister for Health if her Department has commissioned, or plans to commission, an updated national costing of overweight and obesity in Ireland, given that the most recent dedicated study dates from 2012 and current figures rely on academic estimates rather than HSE financial data; and if she will make a statement on the matter. [47828/26]

896. Deputy Ken O'Flynn asked the Minister for Health to reconcile the discrepancy between the 2012 Safefood estimate of €1.13 billion in direct and indirect obesity-related costs in the Republic of Ireland and the 2025 Irish Endocrine Society estimate of €1.1 billion in direct healthcare costs alone; the implications for the true current scale of obesity-related expenditure; and if she will make …

897. Deputy Pearse Doherty asked the Minister for Health the reason the National Treatment Purchase Fund, NTPF, withdrew funding within weeks of a planned orthopaedic operation date for a person (details supplied) in County Donegal; and if she will make a statement on the matter. [47832/26]

898. Deputy Colm Burke asked the Minister for Health the steps being taken to ensure that a life-changing prostate cancer medication, RLT, known as Pluvicto, will be made available to medically suitable patients; and if she will make a statement on the matter. [47846/26]

899. Deputy Joe Neville asked the Minister for Health to update Dáil Éireann on the 10 June 2026 statement of the Beneluxa countries on a unified approach to access to and affordability of medicines; her Department’s engagement in 2026 with Beneluxa countries on this initiative; the possible advancements in pharmaceutical procurement across the Beneluxa countries in 2026 and 2027; and if she will …

900. Deputy Joe Neville asked the Minister for Health when her Department and the HSE will commence work on developing a successor ten-year national cancer strategy given the imminent completion of the term of the 2017-26 national cancer strategy; her plans for developing the new policy, including the timeline for appointment of a chairperson to lead the creation of the strategy; the timeframe for…

901. Deputy Joe Neville asked the Minister for Health her plans to improve accessibility of neurology services and accessibility to beneficial therapies for migraine patients in Ireland; her views on a study (details supplied) on the impact of migraine in Ireland; her views on the plausibility, safety and impact for patients of transferring the management of chronic migraine patients in Ireland fr…

902. Deputy Brian Brennan asked the Minister for Health whether implementation of the Diabetes Policy and Services Review: A strategy for Better Care Diabetes Strategy has been identified as a Ministerial priority within the HSE National Service Plan and Estimates process for 2027; if new funding will be provided in the upcoming budget to support the implementation of the National Diabetes Strateg…

903. Deputy Brian Brennan asked the Minister for Health the plans that are in place to address staffing resource shortages in diabetes services in HSE Dublin and south east; whether extra funding will be made available for the new posts; and if she will make a statement on the matter. [47863/26]

904. Deputy Duncan Smith asked the Minister for Health whether GPs can refer directly for gynaecological pelvic MRI under the GP access to community diagnostics scheme; and if she will make a statement on the matter. [47879/26]

905. Deputy Duncan Smith asked the Minister for Health the reason gynaecological pelvic MRI is not available through GP referral where other MRI indications, including orthopaedic pelvic indications, are available; and if she will make a statement on the matter. [47880/26]

906. Deputy Duncan Smith asked the Minister for Health whether her Department or the HSE plans to review GP access to gynaecological pelvic MRI as part of the national endometriosis framework and wider women’s health policy; and if she will make a statement on the matter. [47881/26]

907. Deputy Duncan Smith asked the Minister for Health whether gynaecological pelvic MRI will be added to GP access pathways under appropriate clinical criteria; and if she will make a statement on the matter. [47882/26]

908. Deputy Duncan Smith asked the Minister for Health if direct GP access to gynaecological pelvic MRI is not proposed, whether the HSE will create a direct GP referral pathway to specialist gynaecological imaging for suspected endometriosis or complex pelvic disease; and if she will make a statement on the matter. [47883/26]

909. Deputy Duncan Smith asked the Minister for Health whether her Department has reviewed the cost and patient impact of funding endometriosis-related care abroad compared with investing in improved diagnostic and treatment pathways in Ireland; and if she will make a statement on the matter. [47884/26]

910. Deputy Liam Quaide asked the Minister for Health the engagement she has had, or that her Department has had, with people who report persistent adverse symptoms following Covid-19 vaccination; whether she or her officials have met individuals, families, clinicians or representative groups on this issue; the dates of any such meetings; the main issues raised; the actions arising; and if her Dep…